PT2467399E - Purificação do vwf para remoção melhorada de vírus sem envelope lipídico - Google Patents

Purificação do vwf para remoção melhorada de vírus sem envelope lipídico Download PDF

Info

Publication number
PT2467399E
PT2467399E PT107471344T PT10747134T PT2467399E PT 2467399 E PT2467399 E PT 2467399E PT 107471344 T PT107471344 T PT 107471344T PT 10747134 T PT10747134 T PT 10747134T PT 2467399 E PT2467399 E PT 2467399E
Authority
PT
Portugal
Prior art keywords
vwf
purification
enveloped viruses
increased removal
lipid enveloped
Prior art date
Application number
PT107471344T
Other languages
English (en)
Portuguese (pt)
Inventor
Hasslacher Meinhard
Mayer Christa
Mitterer Artur
Original Assignee
Baxalta Inc
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2467399(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta Inc, Baxalta GmbH filed Critical Baxalta Inc
Publication of PT2467399E publication Critical patent/PT2467399E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT107471344T 2009-08-20 2010-08-20 Purificação do vwf para remoção melhorada de vírus sem envelope lipídico PT2467399E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23557009P 2009-08-20 2009-08-20

Publications (1)

Publication Number Publication Date
PT2467399E true PT2467399E (pt) 2016-03-18

Family

ID=43063204

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107471344T PT2467399E (pt) 2009-08-20 2010-08-20 Purificação do vwf para remoção melhorada de vírus sem envelope lipídico

Country Status (18)

Country Link
US (1) US9315560B2 (enExample)
EP (1) EP2467399B2 (enExample)
JP (1) JP5838159B2 (enExample)
KR (1) KR101894600B1 (enExample)
CN (2) CN106008697B (enExample)
AU (1) AU2010284116B9 (enExample)
BR (1) BR112012003802B1 (enExample)
CA (1) CA2771232A1 (enExample)
DK (1) DK2467399T3 (enExample)
ES (1) ES2562256T5 (enExample)
HU (1) HUE026907T2 (enExample)
IN (1) IN2012DN01849A (enExample)
MX (1) MX2012002129A (enExample)
NZ (1) NZ598249A (enExample)
PL (1) PL2467399T3 (enExample)
PT (1) PT2467399E (enExample)
SG (2) SG10201408106WA (enExample)
WO (1) WO2011022657A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
KR101772674B1 (ko) 2008-10-21 2017-09-01 박스알타 인코퍼레이티드 동결건조된 재조합 vwf 제제
SG11201408490PA (en) * 2012-06-21 2015-01-29 Baxter Int Virus filtration of cell culture media
US9902942B2 (en) 2013-02-22 2018-02-27 Agency For Science, Technology And Research Chromatographic purification of virus preparations with negatively charged particles
DK3152230T3 (da) * 2014-06-06 2019-11-11 Octapharma Ag Præparat omfattende faktor viii og von willebrand-faktor-peptider
DK3158055T3 (da) 2014-06-13 2019-10-14 Csl Ltd Forbedret produktion af recombinant von willebrand-faktor i en bioreaktor
KR20250088663A (ko) 2017-08-23 2025-06-17 체에스엘 베링 게엠베하 폰 빌레브란트 인자의 바이러스 여과 방법
EP3768697A1 (en) 2018-03-21 2021-01-27 Baxalta Incorporated Separation of vwf and vwf propeptide by chromatographic methods
CA3244889A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) * 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
EP0218692A4 (en) 1985-04-11 1988-03-22 Childrens Medical Center VON WILLEBRAND FACTOR.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
US6531577B1 (en) 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
ES2261589T3 (es) * 1998-05-06 2006-11-16 Genentech, Inc. Composicion de anticuerpos anti-her2.
AU2005322067B8 (en) * 2004-12-27 2012-07-26 Takeda Pharmaceutical Company Limited Polymer-von Willebrand factor-conjugates

Also Published As

Publication number Publication date
DK2467399T3 (en) 2017-01-23
US20110092681A1 (en) 2011-04-21
CN106008697A (zh) 2016-10-12
BR112012003802A2 (pt) 2016-11-22
CN106008697B (zh) 2020-08-04
ES2562256T3 (es) 2016-03-03
AU2010284116B2 (en) 2015-02-12
BR112012003802B1 (pt) 2022-10-25
EP2467399B1 (en) 2015-11-11
NZ598249A (en) 2014-04-30
IN2012DN01849A (enExample) 2015-08-21
EP2467399B2 (en) 2023-02-01
SG178478A1 (en) 2012-04-27
CA2771232A1 (en) 2011-02-24
AU2010284116B9 (en) 2015-03-26
PL2467399T3 (pl) 2016-05-31
JP2013502434A (ja) 2013-01-24
US9315560B2 (en) 2016-04-19
KR101894600B1 (ko) 2018-09-03
ES2562256T5 (es) 2023-07-20
HUE026907T2 (en) 2016-07-28
WO2011022657A1 (en) 2011-02-24
MX2012002129A (es) 2012-06-08
CN102482341A (zh) 2012-05-30
EP2467399A1 (en) 2012-06-27
JP5838159B2 (ja) 2015-12-24
AU2010284116A1 (en) 2012-03-08
KR20120065342A (ko) 2012-06-20
SG10201408106WA (en) 2015-01-29

Similar Documents

Publication Publication Date Title
PT2467399E (pt) Purificação do vwf para remoção melhorada de vírus sem envelope lipídico
EP2334328A4 (en) METHOD FOR CLEANING VIRUSES
ZA201102552B (en) Viral inactivation during purification of antibodies
PL3192874T3 (pl) Oczyszczanie wirusa
IL214434A0 (en) Purification of immunoglobulins
GB0922142D0 (en) Regeneration of absorption solution
SG10201703576WA (en) Oral formulations for promoting cellular purification
IL214374A (en) Deptomycin purification process
IL228609A0 (en) Sustained release silver compound for water purification
IL226926B (en) Elimination of viral activity through the use of an improved solvent-detergent method
PL2417251T3 (pl) Sposób oczyszczania wirusa wścieklizny
GB201012599D0 (en) Process for purifying proteins
EP2471740A4 (en) PROCESS FOR PURIFYING CHLORINEILANE
IL243248A0 (en) Purification method
GB0922140D0 (en) Regeneration of absorption solution
EP2501651A4 (en) PROCESS FOR PURIFYING MONOSILANE
EP2519537A4 (en) CLEANING PROTEINS
ZA201302573B (en) Method for purification of complement factor h
ZA201300320B (en) Purification process
EP2465819A4 (en) PROCESS FOR CLEANING CHLORINEILANES
GB201004372D0 (en) Compounds for purification
PL2585230T3 (pl) Czyszczenie urządzeń do alkilowania katalizowanego HF
GB0906674D0 (en) Regeneration of heat
GB0916016D0 (en) Inactivation of pathogens
GB0918366D0 (en) Viral inactivation